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Dscam encodes a family of cell surface proteins
required for establishing neural circuits in
Drosophila. Alternative splicing of Drosophila
Dscam can generate 19,008 distinct extracellu-
lar domains containing different combinations
of three variable immunoglobulin domains. To
test the binding properties of many Dscam
isoforms, we developed a high-throughput
ELISA-based binding assay. We provide evi-
dence that 95% (>18,000) of Dscam isoforms
exhibit striking isoform-specific homophilic
binding. We demonstrate that each of the three
variable domains binds to the same variable do-
main in an opposing isoform and identify the
structural elements that mediate this self-bind-
ing of each domain. These studies demonstrate
that self-binding domains can assemble in dif-
ferent combinations to generate an enormous
family of homophilic binding proteins. We pro-
pose that this vast repertoire of Dscam recog-
nition molecules is sufficient to provide each
neuron with a unique identity and homotypic
binding specificity, thereby allowing neuronal
processes to distinguish between self and
nonself.
INTRODUCTION
Neurons can distinguish between self and nonself in the
peripheral nervous systems (PNS) of both vertebrates
and invertebrates (Kidd and Condron, 2007; Zinn, 2007).
Self-recognition occurs between sister neurites (i.e., axo-
nal and dendritic branches extending from the same cell)
and results in self-avoidance through contact-dependent
repulsion (Baker and Macagno, 2007; Hughes et al.,
2007; Matthews et al., 2007; Soba et al., 2007). Impor-
tantly, while sister neurites are repelled, nonsister neurites1134 Cell 130, 1134–1145, September 21, 2007 ª2007 Elsevie(i.e., from different cells) do not recognize one another as
self and are not repelled from each other. In this way, self-
avoidance ensures that sister branches segregate from
one another to achieve uniform coverage of receptive
fields while allowing neurites of different neurons to
overlap.
Self-avoidance was first described for axonal pro-
cesses in the leech (Kramer et al., 1985; Kramer and
Kuwada, 1983; Kramer and Stent, 1985) and has sub-
sequently been described for highly branched axonal
processes in the Zebrafish (Sagasti et al., 2005) and for
dendritic branches of neurons in Drosophila (Grueber
et al., 2002; Hughes et al., 2007; Matthews et al., 2007;
Soba et al., 2007). In the early 1980s, Kramer and Kuwada
proposed that self-avoidance is more generally required
for patterning axonal and dendritic processes in the cen-
tral nervous system (CNS) (Kramer and Kuwada, 1983).
Given the vast number of neurons in the CNSwith overlap-
ping dendritic and axonal processes, it seems likely that
many cell surface molecules would be necessary to allow
processes to distinguish between self and nonself.
Previous studies led us to propose that the Ig superfam-
ily proteins encoded by the Drosophila Down’s syndrome
cell adhesionmolecule (Dscam) gene are cell surface mol-
ecules that mediate self-avoidance in the developing CNS
(Neves et al., 2004; Wojtowicz et al., 2004; Zhan et al.,
2004; Zipursky et al., 2006; Wang et al., 2002, 2004).
Dscam encodes 38,016 cell surface proteins with both
variable and constant Ig domains (Figure 1A) (Schmucker
et al., 2000). These isoforms are generated through alter-
native splicing. Each isoform contains a large ectodomain
with ten Ig domains and six fibronectin type III repeats. Of
these, three Ig domains, Ig2, Ig3, and Ig7, contain variable
sequences. Each variable domain is encoded by a block
of alternatively utilized exons containing 12, 48, and 33
exons for Ig2, Ig3, and Ig7, respectively. As splicing within
each block is independent of the other two, the Dscam lo-
cus encodes 19,008 different ectodomains (i.e., 123 483
33) linked to one of two alternative transmembrane
domains. Previously, we demonstrated that 11 Dscam
isoforms exhibit homophilic binding (Wojtowicz et al.,
2004). By contrast, little if any heterophilic binding wasr Inc.
Figure 1. An ELISA-Based Assay for Dscam Binding Specificity
(A) The Dscam gene contains four blocks of alternative exons coding for the first halves of Ig2 (red) and Ig3 (blue), all of Ig7 (green), and the trans-
membrane region (yellow). All isoforms have the same domain structure. Horseshoes represent Ig domains, and black rectangles represent fibronec-
tin type III domains.
(B) Two models for preferential homophilic binding are shown. Previous studies (Wojtowicz et al., 2004), data presented here (see Figure 3), and the
crystal structure by Meijers et al. (2007) support the modular model for homophilic binding. In the lower part of the panel, we schematically represent
how we envision modular binding occurs. Different Ig7 variants are represented by different shapes and different shades of green.
(C) Schematic of ELISA-based binding assay to examine binding between ectodomains. Binding between Dscam ectodomain fused to AP (‘‘recep-
tor’’) and Dscam ectodomain fused to Fc (‘‘ligand’’) is tested. Dscam-AP receptor is captured onto the plate by an anti-AP antibody. The binding of
Dscam-Fc ligand to the receptor is detected by an anti-Fc antibody conjugated to horseradish peroxidase (HRP). HRP activity is measured using
a colorimetric assay as a direct readout of binding between ligand and receptor (see Experimental Procedures).seen between 12 pairs examined. These preferential
homophilic interactions occur in trans between molecules
expressed on opposing cell surfaces (Matthews et al.,
2007).CellRecent studies have demonstrated that Dscam is re-
quired for self-avoidance in the Drosophila PNS (Hughes
et al., 2007; Matthews et al., 2007; Soba et al., 2007).
Here the dendrites of four classes of dendritic arborization130, 1134–1145, September 21, 2007 ª2007 Elsevier Inc. 1135
sensory neurons elaborate overlapping receptive fields.
Whether sister dendrites and the dendrites of neighboring
neurons grow across (i.e., overlap with) one another can
be readily assessed in this system due to the two-dimen-
sional pattern of these processes within the body wall.
While sister dendrites do not overlap, the dendrites of
different neurons overlap extensively. In Dscam mutant
neurons, sister dendrites lose self-avoidance and remain
associated with each other. Gain-of-function studies sup-
port a model for Dscam-mediated homophilic repulsion.
Ectopic expression of the same Dscam isoform in two
neurons, which normally share overlapping receptive
fields, causes their dendrites to recognize one another
as self (Hughes et al., 2007; Matthews et al., 2007; Soba
et al., 2007). This leads to avoidance of nonsister den-
drites and the formation of mutually exclusive receptive
fields. By contrast, deletion of the Dscam cytoplasmic do-
main results in adhesion of dendrites rather than repulsion
(Matthews et al., 2007). Based on these studies, we pro-
posed that Dscam-mediated repulsion proceeds in two
steps. First, homophilic binding occurs between identical
Dscam isoforms expressed on sister dendrites. And sec-
ond, cytoplasmic domain-dependent signaling promotes
receptor downregulation and repulsion. Gain- and loss-
of-function phenotypes are consistent with Dscam-
mediated self-avoidance in both dendrites and axons in
the developing CNS (Hattori et al., 2007; Hummel et al.,
2003; Wang et al., 2002, 2004; Zhan et al., 2004; Zhu
et al., 2006).
For Dscam to provide self-recognition, each neuron
must express different isoforms. Studies by Chess and
colleagues suggest that this is achieved in a stochastic
fashion (Neves et al., 2004). Each neuron is proposed to
express a random set of some 10 to 50 Dscam isoforms.
Due to the large repertoire of Dscam isoforms, it is unlikely
that processes from different neurons, which encounter
each other within the developing brain, will express an ap-
preciable number of the same isoforms. In this way, each
neuron has a unique Dscam identity, which endows its
processes with the ability to recognize self.
To ensure the fidelity of self-recognition, it is essential
that the vast majority of Dscam isoforms exhibit isoform-
specific homophilic binding. This degree of recognition
specificity would be unprecedented outside the verte-
brate immune system. Based on the homophilic binding
properties of 11 isoforms, or 0.06% of the isoforms en-
coded by the locus, we speculated that isoform-specific
homophilic binding is a feature shared by all 19,008
isoforms (Wojtowicz et al., 2004). We proposed that this
specificity is achieved in a modular fashion: Ig2 in one
molecule binds to an identical Ig2 in an opposing mole-
cule, Ig3 binds to an identical Ig3, and Ig7 binds to an iden-
tical Ig7 (Figure 1B). Thus, isoforms sharing the same
combination of variable domains will selectively bind to
each other.
In this paper we present evidence that >18,000 of the
19,008 Dscam ectodomain isoforms exhibit homophilic
binding specificity. We describe a high-throughput ELISA-1136 Cell 130, 1134–1145, September 21, 2007 ª2007 Elsevierbased binding assay which allowed us to screen interac-
tions between thousands of Dscam isoform pairs. We
provide evidence that homophilic binding is achieved in
a modular fashion with each variable domain exhibiting
highly specific self-binding. By swapping specificity deter-
minants between domains, we show that each of the three
variable domains achieves specificity through variations in
sequence within a discrete structural element. Together
these data reveal a novel strategy for generating a vast ar-
ray of cell recognitionmolecules with different specificities
through the mixing and matching of variable modules.
RESULTS
Development of a High-Throughput Dscam
Binding Assay
In order to systematically test the binding specificities of
Dscam isoforms, we developed an ELISA-based binding
assay that provides an efficient method to assess interac-
tions between thousands of isoform pairs (Figure 1C). The
advantages of this assay, when compared with other
binding assays, are outlined in Figure S1 in the Supple-
mental Data available with this article online. The ELISA-
based assay allows the binding properties of proteins to
be assessed without purification and is quantitative over
a 70-fold range (data not shown). Dscam ectodomains
were tested for binding directly from the cell culture
medium, into which they are secreted following small-
scale transient transfection. Ectodomains were gener-
ated in two different C-terminally fused versions to (1)
alkaline phosphatase (Dscam-AP) and (2) human IgG1
Fc (Dscam-Fc). These proteins were quantified (see
Experimental Procedures), the levels of Dscam-AP and
Dscam-Fc were normalized, and binding between them
was tested in an ELISA plate format. Clustering of both
Dscam-AP and Dscam-Fc was essential to detect binding
(Figure S2), thereby suggesting that avidity compensates
for low-affinity interactions between monomers. Experi-
ments were conducted in a grid format wherein homo-
philic interactions are tested along the grid diagonal while
heterophilic interactions are tested off-diagonal. This as-
say has also been used to evaluate the binding properties
of other cell surface proteins (M.Y. Pecot and S.L.Z.,
unpublished data).
Dscam Variable Domains Support
Homophilic Binding
Our previous studies (Wojtowicz et al., 2004), the data pre-
sented in this paper (see below), and the structure of Ig1-4
(containing Ig2.1 and Ig3.34 variable domains) determined
by Meijers et al. (2007) strongly argue that binding speci-
ficity is determined in a modular fashion wherein binding
at each pair of identical variable Ig domains occurs inde-
pendent of the identity of the other variable Ig domains
(Figure 1B). Thus, whether or not the majority of Dscam
isoforms exhibit preferential homophilic binding specific-
ity depends upon whether each of Dscam’s 93 different
variable domains (i.e., 12 different Ig2s, 48 different Ig3s,Inc.
Figure 2. Testing All Dscam Variable Ig Domain Binding Specificities
(A) Three sets of Dscam isoformswere generated as both AP and Fc fusions for the ELISA-based binding assay. Ig3.11, believed to be a pseudo-exon,
was not tested.
(B–D) Binding properties of all Ig2, Ig3, and Ig7 variable domains. Each set of isoforms was tested for binding to all other members of the set. Variable
Ig domains are arranged on the grid axes according to their sequence relatedness as shown in the dendrograms. Binding is indicated as fold over
background by a color scale and the number in each block. The unrelated control isoform 1.30.30 (denoted ‘‘C’’) was used to provide a value for
background binding. The levels of all AP and Fc proteins were normalized (see Experimental Procedures). The average results of duplicate experi-
ments are shown.
(E) Summary of variable domain binding experiments showing the number of Ig2, Ig3, and Ig7 variable domains that exhibit preferential self-binding.
From the self-binding properties of these domains, the number of preferential homophilic binding proteins encoded by the Dscam gene is estimated.and 33 different Ig7s) preferentially binds to an identical
domain in an opposing molecule.
To assess the binding specificity of each variable do-
main, isoforms comprising the N-terminal nine Ig domains
and one fibronectin type III repeat (a region of the ectodo-
main that contains all three variable Ig domains and has
previously been shown to be sufficient for homophilic
binding [Wojtowicz et al., 2004]) were made as both
Fc and AP fusions in three sets: (1) all 12 variable Ig2 do-
mains with a constant Ig3 and Ig7; (2) 47 of the 48 Ig3
domains with a constant Ig2 and Ig7; and (3) all 33 Ig7
domains with a constant Ig2 and Ig3 (Figure 2A). Vari-
able domain Ig3.11 was not tested, as cDNAs encoding
it were not identified. All pairwise combinations within
each set were tested for binding (i.e., 12 3 12 for Ig2,Cell 147 3 47 for Ig3, and 33 3 33 for Ig7). As shown in Figures
2B–2D, all 12 Ig2 variable domains, all 47 Ig3 variable do-
mains, and 32 of 33 variable Ig7 domains support prefer-
ential homophilic binding. Ig7.33 was the only domain that
did not support homophilic binding.
Some variable Ig domains supported heterophilic bind-
ing, which in all cases was weaker than their homophilic
binding. Heterophilic binding occurred largely between
variable domains encoded by closely related alternative
exons as illustrated by the dendrograms in Figure 2. In
some cases (i.e., 24/137) reciprocal binding pairs gave dif-
ferent results. The reason for this is unknown. Each heter-
ophilic pair was tested in a reciprocal fashion (i.e., A-AP to
B-Fc and B-AP to A-Fc). There were eight examples of
heterophilic binding out of the 132 Ig2 pairs tested (6%),30, 1134–1145, September 21, 2007 ª2007 Elsevier Inc. 1137
110 out of the 2162 Ig3 pairs tested (5%), and 19 out of the
1058 Ig7 pairs tested (2%).
Variable Ig Domain Binding Is Modular
The Ig2, Ig3, and Ig7 grid binding experiments support the
modular model for homophilic binding (i.e., three separate
interfaces); however, they do not rule out the possibility
that all three variable domains contribute jointly to the gen-
eration of a single interface (see Figure 1B). If the modular
model is correct, then the binding profile of each variable
domain (i.e., the domains with which it exhibits hetero-
philic interactions and the domains with which it does
not) will be independent of the identity at the other two var-
iable domains (Figure 3A). This will not be the case if all
three variable domains combine to form a single interface.
We selected a subset of variable domains from the Ig2,
Ig3, and Ig7 binding grids that support heterophilic binding
to some variants but not to others and tested them for
binding in a different context. For example, Ig2 domain
variants were placed in the context of a different Ig3 and
Ig7 from those used in the initial grid experiments in
Figure 2B. We observed that the unique binding profiles
of individual variable domains are exhibited independent
of the context of the other two variable domains (as indi-
cated by the identical grid patterns in Figure 3B). These
findings strongly argue that binding specificity arises
from a modular molecular strategy of Ig2 to Ig2, Ig3 to
Ig3, and Ig7 to Ig7 binding.
In summary, the vast majority of variable domains
(i.e., 91/93) exhibit preferential self-binding. This binding
occurs independent of the identity at the other variable
domains for all domains tested (i.e., 15/93). Modular
self-binding at each variable domain provides a molecular
strategy for achieving homophilic specificity. These find-
ings argue that the vast majority of Dscam isoforms (i.e.,
12 3 47 3 32 = 18,048) exhibit preferential homophilic
binding.
The Molecular Logic of Variable Ig Domain
Self-Binding
To achieve highly specific self-binding at each of the three
variable domains, one molecular strategy for self-recogni-
tion may have evolved that was then utilized by all three
variable domains, or alternatively, each of the three vari-
able domains may have evolved a unique strategy. We
therefore sought to assess how self-binding is achieved
at each of the three variable domains. We reasoned that
(1) if closely related domains bind weakly or not at all to
one other, then one or more of the residues that differ
between them must be critical for determining binding
specificity, and (2) specificity residues would be surface
exposed and localized within a discrete region or element
within the domain.
To identify candidate specificity-determining residues,
we used primary amino acid sequence analysis, the bind-
ing properties of closely related Ig domains, molecular
modeling (for Ig7), and the crystal structure of Ig1-Ig4
(containing Ig2.1 and Ig3.34) solved by Meijers et al.1138 Cell 130, 1134–1145, September 21, 2007 ª2007 Elsevier(2007) and communicated to us prior to publication. If
amino acid differences within the specificity-determining
elements of the variable domains confer unique binding
properties to isoforms, then ‘‘swapping’’ these differences
between variable domains should swap their binding
specificity (Figure 4A). The specificity-swapping approach
enabled us to identify sequences that are not only neces-
sary but sufficient to confer unique binding properties to
each of the three variable Ig domains. Representative
examples of specificity swapping are shown for all three
variable domains in Figures 4 and 5. Many additional
examples are shown in Figures S4–S6.
Ig2 and Ig3 Specificity-Determining Residues
Reside on Single Strands
Ig1-4 fragments of Dscam form dimers in the crystal struc-
ture as determined by Meijers et al. (2007). The binding in-
terface is defined by an antiparallel pairwise matching of
Ig2 to Ig2 and Ig3 to Ig3. The Ig2-Ig2 binding interface
occurs between the same b strand, called the A0 b strand,
in eachmonomer (Figure 4B). The Ig3-Ig3 interface occurs
along a segment between two b strands, called the A–A0
segment, which loops away from each domain much like
a teapot handle (Figure 4C).We reasoned that, if swapping
Ig2 A0 b strands and Ig3 A–A0 segments swaps binding
specificity in diverse Ig2 and Ig3 variants, then in all likeli-
hood, the variation within these discrete structural ele-
mentsdetermines the specificity of all Ig2 and Ig3domains.
To assess whether residues along the A0 b strand are
sufficient to confer the binding specificity of Ig2 variants,
we first swapped the surface-exposed strand residues
that form direct contacts between interacting Ig2 mono-
mers in the crystal structure. Surprisingly, isoforms con-
taining surface-swapped Ig2 domains did not have swap-
ped binding specificity. Instead, they exhibited both
homophilic and robust, promiscuous heterophilic binding
(Figure S3). We reasoned that the inward-facing residues,
along with the surface-exposed residues, on the A0
b strand contribute to specificity. Therefore, we swapped
the entire A0 b strand between pairs of variable Ig2 do-
mains and the entire A–A0 segment between pairs of vari-
able Ig3 domains. Strand swaps were performed for all 12
Ig2 variable domains, and segment swaps were per-
formed for seven highly diverse Ig3 domains sharing as
low as 22% amino acid sequence identity.
All entire strand and segment-swapped isoforms
bound to isoforms with which they shared strand or seg-
ment identity regardless of the identity of the remainder
of the variable domain (i.e., domain backbone) (Figures
4B and 4C; Figures S4 and S5). They bound to themselves
(i.e., homophilically). They did not bind to the wild-type
isoform from which they were generated (i.e., isoform
with the same domain backbone but different strand or
segment). Importantly, swapped isoforms now bound to
the wild-type isoform with which they shared strand or
segment identity in spite of a differing domain backbone.
This argues that the A0 b strand and the A–A0 segment
are the specificity elements for most, if not all, Ig2 andInc.
Figure 3. Modular Variable Ig Domain Interactions Give Rise to Homophilic Binding Specificity
(A) According to the modular model, the binding properties of each variable domain are independent of the identity of the other two variable domains.
Therefore, domains should exhibit the same binding properties (i.e., the same pattern of homophilic and heterophilic binding) regardless of the identity
of the other two variable domains (i.e., context). Different Ig7 variants are represented by different shapes and different shades of green. Different Ig2
and Ig3 variants are denoted by different shades of gray and different shapes.
(B) The binding properties of a subset of Ig2, Ig3, and Ig7 variable domains were tested in two different contexts. The data in the left-hand column (i.e.,
context #1) were taken from the grids in Figure 2. Binding is indicated as fold over background by a color scale and the number in each block. In
context #1 experiments, the context #2 isoform was used as a negative control (denoted ‘‘C’’) for binding and vice versa. The average results of
duplicate experiments are shown.Ig3 domains, respectively. Thus, these short contiguous
polypeptide stretches are both necessary and sufficient
for homophilic binding specificity within the Ig2 and Ig3
domains.Cell 1Ig7 Specificity-Determining Residues Reside
on Multiple Strands
Asacrystal structureof Ig7 is not available,weusedacom-
bined biochemical and modeling approach to define the30, 1134–1145, September 21, 2007 ª2007 Elsevier Inc. 1139
Figure 4. Characterization of the Ig2 and
Ig3 Specificity Elements
(A) Experimental design to assess variable Ig
domain specificity determinants.
(B) Spacefill models of wild-type variable Ig2
domains and A0 b strand-swapped Ig2 do-
mains are shown. Different Ig2 variants are
represented by different shades of red. The
sequence alignment shows the A0 b strand
sequences (residues 105–114) for these Ig2
domains. The binding properties of isoforms
containing wild-type and strand-swapped Ig2
domains were tested. Binding is indicated as
fold over background by a color scale and
the number in each block. The unrelated con-
trol isoform 1.30.30 (denoted ‘‘C’’) was used
to provide a value for background binding.
The average results of duplicate experiments
are shown. Many additional strand swaps
(>10) show the same results (see Figure S3).
(C) Spacefill models of wild-type variable Ig3
domains and A–A0 segment-swapped Ig3 do-
mains are shown. Different Ig3 variants are
represented by different shades of blue. The
sequence alignment shows the A–A0 segment
sequences (residues 214–224) for these Ig3
domains. Other segment-swapped Ig3 do-
mains also show swapped binding specificity
(see Figure S4). Specificity strands predicted
according to Ig2.1 and Ig3.34 interfaces in
the Ig1-4 structure (Meijers et al., 2007).specificity determinants in Ig7. Candidate Ig7 specificity-
determining residues were identified using three closely
related Ig7 domains that exhibited little or no heterophilic
binding to each other. There are seven to nine amino
acid differences between each pair. They all differ at resi-
due23, residue61, or both (Figure 5A).Molecularmodeling
using homology fold recognition servers (i.e., PHRYE,
FUGUE, and ESyPred3D) placed residues 23 and 61 adja-
cent to each other on neighboring b strands on one face of
the domain. To test whether they are specificity-determin-
ing residues, we swapped thembetween domains and as-
sessed the binding properties of new isoforms resulting
from the swaps. Swapped isoforms exhibited the following
binding properties: (1) each bound to itself (i.e., homophilic
binding); (2) each lost the ability to bind to the wild-type
isoform from which it was derived (i.e., sharing the same
domain backbone but a different specificity-determining
residue[s]) and; (3) each acquired the ability to bind to the
other wild-type isoform that contained identical residues
at the swapped positions. Thus, swapping these residues1140 Cell 130, 1134–1145, September 21, 2007 ª2007 Elsevierswapped the binding specificity of Ig7 domains. Interest-
ingly, for Ig7 variants that differed at both residues 23
and 61, swapping only one residue did not swap binding
specificity but instead generated Ig7 variants with new
preferential homophilic binding specificity (Figure S6A).
These data demonstrate that residues 23 and 61 are Ig7
specificity-determining residues for these Ig7 variants
and argue that they are localized at the Ig7-Ig7 interface.
Molecular Modeling of the Ig7-Ig7 Interface
To gain insight into how self-binding of Ig7 variants may
occur, we used the Rosetta (R. Das, B.Q., S. Raman, R.
Vernon, J. Thompson, P. Bradley, S. Khare, M.D. Tyka,
D.Bhat, D.C.Chivian, D.E. Kim,W.Sheffler, L.Malmstro¨m,
A.M. Wollacott, C. Wang, I.A., and D. Baker, unpublished
data) program to build homology models of two Ig7 vari-
ants (Ig7.25 and Ig7.20) and then generated symmetric
homodimeric complexes through protein-protein docking
(I.A., P.Bradley,C.Wang, andD.Baker, unpublisheddata).
Modelswere filtered based ondistance constraints forcingInc.
Figure 5. The Specificity Element in Ig7
Comprises Multiple b Strands
(A) Spacefill model of Ig7.25 generated us-
ing homology fold recognition servers (i.e.,
PHRYE, FUGUE, and ESyPred3D) showing
two candidate specificity-determining resi-
dues (purple and orange) located on adjacent
b strands. A key shows the identity of these
two residues in each wild-type and residue-
swapped Ig7 domain. Different Ig7 variants
are represented by different shades of green.
Residue 23 was swapped between Ig7.25
and Ig7.26 (note that these Ig7 variants engage
in low levels of heterophilic binding with each
other). Residue 61 was swapped between
Ig7.20 and Ig7.26. Residues 23 and 61 were
swapped between Ig7.20 and Ig7.25. The
binding properties of isoforms containing
wild-type and residue-swapped Ig7 domains
were tested. Binding is indicated as fold over
background by a color scale and the number
in each block. The unrelated control isoform
1.30.30 (denoted ‘‘C’’) was used to provide
a value for background binding. The average
results of duplicate experiments are shown.
(B) Distribution of bindingmodes resulting after
symmetrical protein-protein docking of homol-
ogy models of Ig7.25. Ten different models
generated using Rosetta (R. Das, B.Q., S.
Raman, R. Vernon, J. Thompson, P. Bradley,
S. Khare, M.D. Tyka, D. Bhat, D.C. Chivian,
D.E. Kim, W. Sheffler, L. Malmstro¨m, A.M.
Wollacott, C. Wang, I.A., and D. Baker, unpub-
lished data) are used as a starting point
for symmetrical docking (I.A., P. Bradley, C.
Wang, and D. Baker, unpublished data). The
lowest-energy models from each docking
experiment are collected, and the positions of
Ca atoms of residue 23 (purple) and 61 (or-
ange) (in the center of the proposed binding
region) in onemonomer are shown. Residue 63
(blue) is included as a reference point. (Left
panel) Unconstrained docking models. (Middle
panel) Docking models constrained using a distance constraint of 8 A˚ between residue 61 in both monomers. (Right panel) Docking models addition-
ally filtered to include models in which residue 23 is also within 8.0 A˚ of itself in the other monomer.
(C) Two dockingmodels for Ig7.25 are shown. One Ig7.25monomer is shown in cartoon (cyan), and the other is shown in spacefill (green). Two images
on the right show the corresponding specificity-determining residues 23 and 61 at the center of the interface of the Ig7.25 monomers in both docking
models. Using the docking model as a guide, other residues at the Ig7 dimer interface were identified and tested (see Figure S6B).contacts between specificity-determining residues 23
and/or 61 across the interface, and the lowest energy
structures were selected (Figure 5B and Figure S7). The
conformations adopted by these low-energy structures
range from a strict antiparallel orientation, which is most
favored, to a criss-crossed antiparallel orientation (Fig-
ure 5C). Both binding modes place amino acids 23 and
61 adjacent to each other on neighboring b strands in the
center of the Ig7-Ig7 interface. The docked complexes
provide a basis for interpreting the experimental data and
can be evaluated and further refined with input of addi-
tional experimental constraints.
The docked Ig7 complexes suggest a speculative
model (Figure S8) for the physical origins of self-binding
for the Ig7 variants differing at residues 23 and/or 61.Cell 13Both of these switches involve a change of a Met residue
to a b-branched amino acid, either Thr or Val. Inspection of
the docked complexes shows that interdigitated Met-Met
pairs and face-on-face b-branched Val-Val or Thr-Thr res-
idue pairs can pack quite well, while heterotypic Met-Val
or Met-Thr pairs are considerably less optimal as the b-
branching prevents interdigitation of the long linear Met
residue.
We sought to assess whether the docked Ig7.25 and
Ig7.20 complexes can be generalized to other Ig7 do-
mains. Not all Ig7 pairs differ at residues 23 and 61, sug-
gesting that additional residues at the Ig7-Ig7 interface
contribute to binding specificity. By swapping interface
residues that differ between other pairs of Ig7 variants,
additional residues on three neighboring b strands at the0, 1134–1145, September 21, 2007 ª2007 Elsevier Inc. 1141
docking interface were shown to affect binding. For two
pairs of Ig7 variants we observed a complete swap in
binding specificity, indicating that some or all of the swap-
ped residues are at the interface. For two other pairs of Ig7
variants binding was affected, but specificity was not
swapped. In these cases we observed partial swaps in
specificity or reductions in homophilic binding, suggesting
that some or all of these residues are also at the interface
(Figure S6B and data not shown). As six of the Ig7 domains
used in these swapping experiments are not closely re-
lated to the Ig7 domains used for modeling, it is likely
that the modeled interface represents the interface for
many, if not all, variable Ig7 domains.
DISCUSSION
In this paper we provide evidence that the vast majority of
Dscam isoforms exhibit preferential homophilic binding
and thus provide an enormous repertoire of cell recogni-
tion proteins.We demonstrate that preferential homophilic
binding specificity arises through amolecular strategy that
involves modular interactions between distinct structural
elements within each of the three variable Ig domains. It
is likely that the in vitro binding properties we have de-
scribed here translate into cell recognition events in vivo,
as two populations of cells in culture expressing isoforms
differing by only a single amino acid at the Ig7 interface
readily segregate into isoform-specific aggregates (Mat-
thews et al., 2007).
How Is the Remarkable Binding Specificity
of Dscam Isoforms Achieved?
The proliferation of different homophilic specificities dem-
onstrated in this paper is, to our knowledge, unprece-
dented. While there are other families of homophilic rec-
ognition proteins, they are several orders of magnitude
smaller than Dscam (e.g., 20 different proteins for the
classical cadherins in vertebrates) (Uemura, 1998). Struc-
tural and biochemical studies have provided insights into
the mechanisms underlying cadherin specificity (Boggon
et al., 2002; Patel et al., 2006). Here specificity is deter-
mined by sequences within a single self-binding domain.
This self-binding domain mediates homophilic binding
between opposingmolecules. The domains orient in a par-
allel fashion, and a strand is swapped between them to
stabilize the homophilic interaction. Our studies reported
here and the crystal structure reported by Meijers et al.
(2007) argue that the structural basis for Dscam isoform-
specific homophilic binding is fundamentally different. In
Dscam, binding specificity is determined by three self-
binding domains, each oriented in an antiparallel fashion.
Deciphering the molecular mechanisms that underlie
this multitude of antiparallel self-binding domains is a fas-
cinating challenge for structural biophysics. In the crystal
structure of Ig2.1 and Ig3.34 (Meijers et al., 2007), the
antiparallel interfaces are formed between opposing A0
b strands and A–A0 segments, respectively. Interactions
between these antiparallel sequences form a 2-fold sym-1142 Cell 130, 1134–1145, September 21, 2007 ª2007 Elseviermetric network of hydrogen bonds and salt bridges.
When compared to one another, the 12 different Ig2 A0
b strands and the 47 different Ig3 A–A0 segments have
multiple amino acid differences. Our findings strongly sug-
gest that they all mediate self-binding. We propose that
self-binding for all Ig2 and Ig3 variable domains is speci-
fied by unique 2-fold symmetric networks of interactions
between amino acids within these short polypeptide
sequences.
Modeling andmutagenesis studies suggest that Ig7 do-
mains also associate in an antiparallel fashion. In contrast
to Ig2 and Ig3, Ig7 specificity is determined by a unique
combination of residues on multiple b strands comprising
one face of the Ig domain. If the Ig7 interface is oriented in
a strictly antiparallel fashion, then like Ig2 and Ig3, binding
will be determined by a 2-fold symmetric network of inter-
actions. Whether the Ig7 interface is oriented in a strictly
antiparallel or in a criss-cross antiparallel orientation, it is
surprising that swapping a single amino acid at the center
of the interface swaps binding specificity. In the case of
heterophilic interactions in other proteins, alterations in
binding specificity involve compensatory changes such
as swapping a big-small residue pair for a small-big resi-
due pair. This cannot be the case for changes in binding
specificity at the center of symmetric homodimeric inter-
faces, as the same residue change occurs in both mono-
mers. One way specificity could be achieved is illustrated
in Figure S8. Here, the complete specificity swaps brought
about by changes at the center of the interface (i.e., Met to
Val andMet to Thr; see Figure 5 and Figure S6) could result
from favorable interactions between opposing long/thin
Met residues, which can interdigitate, and between op-
posing short/fat b-branched Val and Thr residues, which
can pack face-on-face. By contrast, unfavorable packing
between opposedMet and b-branched Val or Thr residues
disfavor heterodimer formation.
How can a single residue change in only one of the three
variable Ig domains prevent binding between isoforms?
Differences in binding specificity between isoforms differ-
ing at only a single residue suggest that binding energy
differences favoring self-binding need not be large. As de-
tection of homophilic binding specificity requires oligo-
merization, avidity effects arising from the multivalency
of Dscam interactions magnify these small differences in
binding energy. That oligomerization of weakly interacting
molecules can lead to strong binding has previously been
described for other cell surface molecules (Shapiro et al.,
1995, 1996).We propose that the vast repertoire of Dscam
homophilic binding specificities arises through a combina-
tion of multiple low-energy interactions at each of the
three variable domains and avidity.
The Evolution of Dscam Homophilic
Binding Specificities
As thousands of neurites from many different neurons in-
termingle in densely packed regions of the brain, the vast
majority of Dscam isoforms must exhibit homophilic bind-
ing specificity for Dscam to mediate the phenomenonInc.
of self-avoidance. The binding studies presented here
show that (1) Dscam homophilic binding is modular, (2)
91 of 93 variable domains exhibit preferential self-binding,
and (3) only a small fraction (i.e., 2%–6%) of variable do-
mains show any nonself binding. Together, these data
argue that >18,000 Dscam isoforms exhibit preferential
homophilic binding. This molecular self-recognition pro-
vides a robust mechanism for neurite self-recognition
and avoidance in the developing brain. In this way, Dscam
molecules function as identification tags for individual
neurons. Whether Dscam isoforms also function as tags
to mediate interactions between neurons, as envisioned
by Sperry, remains to be critically addressed (Sperry,
1963).
How did so many self-binding variable domains arise?
Each block of alternative exons encoding the Dscam vari-
able domains presumably evolved by exon duplication fol-
lowed by sequence divergence (Graveley et al., 2004). Iso-
forms containing new variable domains may have lost the
ability to bind to isoforms containing the variable domain
fromwhich they diverged, exhibited promiscuous binding,
or acquired a new homophilic binding specificity. Indeed,
in our swapping experiments we generated variable do-
mains that exhibited each of these properties. These
data strongly argue that alternative exons diverged until
self-binding variable domains arose. We propose that
the essential role for efficient self-avoidance in the CNS
provided the selective pressure to maintain them.
EXPERIMENTAL PROCEDURES
Plasmid Construction
Generation of Dscam-Fc and Dscam-AP Constructs
Dscam 7.27.25 EC10 containing the N-terminal nine Ig domains
followed by one fibronectin type III repeat was subcloned into the
pIB-V5/His vector (Invitrogen) in-frame with (1) the Fc region of human
IgG1 or (2) human placental alkaline phosphatase (AP) as follows. (1)
The vast majority of the pIB-V5/His MCS was destroyed by double re-
striction digestion with HindIII and EcoRV, Klenow treatment, and reli-
gation to generate pIBDMCS; (2) the Fc region of human IgG1was PCR
amplified from an EST using an upstreamprimer containing 50 XhoI and
SpeI sites and a downstream primer containing a 50 XbaI site; (3) AP
was PCR amplified from APtag-2 (Flanagan and Leder, 1990) using
primers containing the same sites; 4) Fc and AP PCR fragments
were digested with XhoI and XbaI and subcloned into XhoI and XbaI
sites in the MCS of pIBDMCS to generate pIBDMCS-Fc and pIBDMCS
-AP, respectively; and (5) Dscam 7.27.25 EC10 (including signal
peptide) was PCR amplified using an upstream primer containing
a 50 NotI site and a downstream primer containing a 50 SpeI site and
subcloned in-frame and upstream of Fc and AP to generate pIBDMCS
7.27.25 EC10-Fc and pIBDMCS 7.27.25 EC10-AP, respectively.
To generate a universal pIBDMCS 7.27.25 EC10-Fc vector that
would allow variable Dscam exons to be easily swapped, unique
SacI and HpaI restriction sites were introduced by silent point muta-
tions in exons 5 and 7, respectively, using site-directed mutagenesis.
Exon 3 contains a unique AatII site, thereby allowing the swapping of
variable exon 4 by AatII-SacI double digest. SacI-HpaI sites in exons
5 and 7 were used to swap variable exon 6. The two XhoI sites in
pIBDMCS 7.27.25 EC10-Fc reside in exons 8 and 10 flanking variable
exon 9 and were used to swap exon 9, followed by PCR amplification
to check for orientation. Nearly all of the variable exons were present in
Dscam exon3-10 cDNA library clones (Schmucker et al., 2000; ZhanCellet al., 2004) (D. Hattori and S.L.Z., unpublished data), and those not
present were amplified from cDNA in two PCR steps using primers
that annealed within the variable exon. Ninety-two out of the ninety-
three Ig2 (exon 4), Ig3 (exon 6), and Ig7 (exon 9) encoding variable
exons were obtained. Each variable exon was PCR amplified using
primers containing the unique restriction sites described above and
purified to generate a library of variable exons for subcloning into
pIBDMCS 7.27.25 EC10-Fc to generate the Ig2, Ig3, and Ig7 series
containing all variable exons.
To generate Dscam-AP constructs, the EC10 region from the
Dscam-Fc clones for each isoform was subsequently subcloned into
the pIBDMCS-AP vector by NotI-SpeI double digestion. All isoforms
used in this study were prepared by swapping exons into the universal
pIBDMCS 7.27.25 EC10-Fc vector. All mutagenesis was performed
using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) ac-
cording to the manufacturer’s protocol. Primer sequences available
upon request.
Protein Expression, Detection, and Quantification
Dscam EC10-Fc and Dscam EC10-AP proteins were expressed
by transient transfection of Drosophila S2 cells as follows: 5 3 106
cells/well were seeded in 6-well cell culture plates in 1.6 ml
Schneider’s Drosophila medium (Invitrogen) containing 10% Ultra-
Low IgG FCS (Invitrogen) and pen-strep (Invitrogen) at 25C and al-
lowed to grow overnight. Cells were transfected with 0.8 mg pIBDMCS
Dscam EC10-Fc or pIBDMCS Dscam EC10-AP using Effectene re-
agents (6.4 ml Enhancer and 40 ml Effectene; QIAGEN) and incubated
for 6–7 days at 25C, during which time secreted Dscam EC10-Fc
and Dscam EC10-AP proteins accumulated in the culture medium.
Culture medium was harvested, spun 10 min at 1000 rpm in a tabletop
centrifuge to pellet cells, filtered (0.2 mm), and stored at 4C. Proteins
(includingAPactivity) remainedstable inculturemediumat4Cfor>2years
without appreciable loss of binding activity.
Dscam EC10-Fc and Dscam EC10-AP proteins were analyzed by
SDS-PAGE and immunoblotting for Fc or AP to test for expression
and size. Quantitative immunoblotting using a Typhoon scanner (GE
Healthcare) and ImageQuant software was performed with known
concentrations of purified Dscam EC10-Fc (purified as in Wojtowicz
et al. [2004]) to determine the concentrations of DscamEC10-Fc in cul-
ture media. The levels of Dscam EC10-AP in culture media were quan-
tified by AP enzymatic activity following addition of substrate (Pierce)
relative to the activity of purified calf intestinal phosphatase (CIP)
(Pierce). Absorbance at 605 nm was measured using the SpectraMax
340 PC microplate spectrophotometer (Molecular Devices). Following
quantification, protein levels were normalized to 8 ng/ml (Dscam
EC10-Fc) and 4 U/ml (Dscam EC10-AP; where a unit [U] is equivalent
to the activity of 10 pg purified CIP) by addition of mock-transfected
culture media.
ELISA-Based Binding Assay
Binding between Dscam EC10-Fc and Dscam EC10-AP was tested in
an ELISA-based format. Each well of Nunc Immunosorp 96-well plates
was incubated overnight at 4Cwith 50 ml 3 mg/ml of a mouse antibody
to AP (IgGAb-1 clone 8B6.18) (NeoMarkers) in 13 PBS (pH 7.4). Wells
were washed three times for 1–3 min at room temperature with 400 ml
13 PBS (pH 7.4) + 0.05% Tween-20 (PBST). Wells were incubated for
1–2 hr at room temperature with 400 ml 1% casein in 13 PBS (pH 7.4).
The 1% casein block was removed. This was followed by the addition
of 20 ml Dscam EC10-Fc (8 ng/ml) and 20 ml Dscam EC10-AP (4 U/ml)
culture medium containing monoclonal mouse anti-human IgG1-
HRP (2 mg/ml; Serotec). Plates were covered and incubated 4 hr at
room temperature protected from light. Wells were washed three times
for 1–3 min at room temperature with PBST. 1-Step Ultra TMB-ELISA
HRP substrate (100 ml; Pierce) equilibrated to room temperature was
added, and plates were incubated 1 hr at room temperature. Absor-
bance at 450 nm was measured using the SpectraMax 340 PC micro-
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All assays were done under the same conditions. Conditions were
established using previously characterized isoforms (Wojtowicz
et al., 2004) such that homophilic binding was 20- to 60-fold higher
than background. Binding between isoforms differing at all three vari-
able Ig domains was equivalent to background levels obtained in the
absence of ligand. Therefore, in all binding assays an unrelated control
isoform was included that differed by at least two, and usually three,
variable Ig domains from those tested. The binding level between the
control isoform and the tested isoforms provided an average back-
ground binding value. The concentrations of Dscam EC10-Fc, Dscam
EC10-AP, and monoclonal mouse anti-human IgG1-HRP used in the
assay were optimized so that binding between two previously charac-
terized isoforms that are identical at variable domains Ig2 and Ig3 and
differ only by seven residues in variable domain Ig7 (i.e., 7.27.25 and
7.27.26) was readily observed (i.e., 5-fold over background).
Immunoprecipitation
Pull-downs were performed in 200 ml RIPA buffer (150 mM NaCl, 10%
glycerol, 0.5% deoxycholate, 50 mM Tris (pH 8.0), 0.4 mM EDTA (pH
8.0), 1%NP-40, 0.1% SDS) and contained all or some of the following:
20 ml ImmunoPure Immobilized Protein G (Pierce), 150 ng/ml purified
1.30.30 Dscam EC16-Fc containing the entire extracellular domain of
Dscam fused to Fc (purified as in Wojtowicz et al. [2004]), 500 ng/ml
purified 1.30.30, or 7.27.25 Dscam EC8-His containing the first eight
immunoglobulin domains of the extracellular domain (a region suffi-
cient for homophilic binding) fused to a 6XHis tag (Caltech Protein
Expression Facility), and 10 ng/ml a-His conjugated with HRP (Penta-
His HRP; QIAGEN; Lot # 12183222). Pull-downs were incubated over-
night at 4C on a Nutator and washed three times for 5 min with 200 ml
RIPA buffer at 4C on a Nutator. Wash buffer was removed, 25 ml 23
SDS loading buffer (containing b-mercaptoethanol) was added, sam-
ples were boiled 5 min, and 10 ml was analyzed on 8% SDS-PAGE
gels. Semidry transfer was performed for 35 min at 15V onto Immobi-
lon-P membrane (Miilipore). Membranes were blocked in 13 TBST
containing 5% milk (a-Fc immunoblot) or 10 mM Tris (pH 7.7),
150 mM NaCl, 1% casein, 0.1% Tween-20 (a-His IgG immunoblot)
for 1 hr at room temperature. Immunoblotting was performed in block-
ing buffer with 1:5000 goat a-human IgG-HRP (Bio-Rad) or a-His IgG-
HRP (Penta-His HRP; QIAGEN; Lot #12183222). Membranes were
washed six times for 10 min in blocking buffer, rinsed with 13 TBST,
incubated 5 min with SuperSignal West Pico Chemiluminescent
Substrate (Pierce), exposed, and developed.
Molecular Modeling
Homology Modeling
The amino acid sequence to be modeled was threaded onto the best
template backbone, and regions containing insertions or deletions
relative to the template were built using an improved version of the
Rosetta loop modeling protocol (R. Das, B.Q., S. Raman, R. Vernon,
J. Thompson, P. Bradley, S. Khare, M.D. Tyka, D. Bhat, D.C. Chivian,
D.E. Kim, W. Sheffler, L. Malmstro¨m, A.M. Wollacott, C. Wang, I.A.,
and D. Baker, unpublished data) which incorporates CCD closure
followed by gradient based energy minimization. Side chains were
modeled using a combinatorial search through an extended version
of the Dunbrack rotamer library supplemented with side-chain con-
formations from the template using Monte Carlo sampling. Full-chain,
all-atom refinement was then carried out with the Rosetta all-atom
energies. Several thousand structure models were generated using
the above protocol, and the structures with the lowest Rosetta all-atom
energies were used as the predicted models.
Protein-Protein Docking
For Ig7.20 and Ig7.25 onemember from each of the ten lowest-scoring
clusters from homology modeling was selected for symmetrical
protein-protein docking in order to produce models of homophilic
interactions. The method carries out simultaneous optimization of
side-chain rigid-body degrees of freedom while restricting the search
space to symmetrical conformations of backbone and side-chains1144 Cell 130, 1134–1145, September 21, 2007 ª2007 Elsevier(I.A., P. Bradley, C. Wang, and D. Baker, unpublished data). Around
105 models were generated per starting. In a second simulation,
models were given an energy bonus score if a distance of less than
8 A˚ between residues 61 across the interface was observed, and
only models meeting the distance criteria were collected. These
models were then filtered to select those models that additionally
had less than 8 A˚ between residues 23 across the interface and
to find models that place both residue pairs together.
Supplemental Data
The Supplemental Data include eight figures and Supplemental Refer-
ences and can be found with this article online at http://www.cell.com/
cgi/content/full/130/6/1134/DC1/.
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